mdINR 1.0


Category: Medical
Price: Free (iTunes)

Description:

mdINR is an electronic diary for patients on anticoagulation therapies, especially patient performing home testing of their PT/INR (Patient Self-Testing, or “PST”). This version, the first mobile application ever developed for patients on anticlotting medications, supports Coumadin (Warfarin).

Patients taking Coumadin (a trademark of Bristol-Myers Squibb Phara Company) can use the mdINR application on their iPhone or iTouch to track their daily dose of Coumadin, to schedule future home PT/INT tests and physician office visits, to auto-generate reminders on critical PT/INR test days, and to track INR test results. Furthermore, a daily notes function enables patients to record events that could affect clotting function or cause fluctuations in the PT/INR (for example, a change in diet or the sudden introduction of certain antibiotics).

Patients using mdINR on a daily basis may prevent missed or double doses and will have a detailed electronic record of their PT/INR and dosing history to share with their physician for improved clinical decision making.

Version 2, currently under production and due for release in May, 2009, will support generic Warfarin, dynamically manage diary information through the mdINR.com website, and provide physicians (with their patient’s prior permission) with access to their patient’s information with critical alerts (will support email or SMS) when PT/INR results are outside the desired therapeutic range.

mdINR is a free application. It is our sincere hope that both patients and providers will find mdINR a useful tool to maintain consistent therapeutic ranges, to provide better information for clinical decisions, and to prevent negative outcomes. We only request that you provide us with feedback to help us improve mdINR as we release future versions. Help us make a positive impact on the lives of patients on anticoagulation therapies.



mdINR



更多...